262606 Factors Associated with Colorectal Cancer Screening Adoption Among Chinese Americans: A Stages of Change Perspective

Tuesday, October 30, 2012 : 8:42 AM - 8:54 AM

Janice Y. Tsoh, PhD , Department of Psychiatry, UCSF, San Francisco, CA
Adam Burke, PhD, MPH, LAc , Health Education/Holistic Health Studies, San Francisco State University, San Francisco, CA
Ginny Gildengorin, PhD , Department of Medicine, University of California, San Francisco, San Francisco, CA
Gem Le, PhD , Department of Medicine, UCSF, San Francisco, CA
Elaine Chow, BS , NICOS Chinese Health Coalition, San Francisco
Ching Wong, BS , Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA
Rena Pasick, DrPH , Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA
Kent Woo, MSW , NICOS Chinese Health Coalition, San Francisco, CA
Lei-Chun Fung, MPH, MSW , Health Education Department, Chinatown Public Health Center, San Francisco, CA
Susan Stewart, PhD , Division of Biostatistics, University of California-Davis, Davis, CA
Stephen McPhee, MD , Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA
Tung T. Nguyen, MD , Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA
Background: Colorectal cancer (CRC) screening rates remain low among Chinese Americans. Factors associated with CRC screening adoption in this population are not well understood.

Methods: Cross-sectional data from a convenience sample of 319 Chinese Americans aged 50-75 (23% male; 64% spoke English poorly or not at all) were analyzed to examine factors associated with stage of CRC screening adoption.

Results: Based on self-reports, 55% were in the “Action” stage (up-to-date for screening), 14% in “Contemplation” stage (planned for screening within 6 months), and 31% in Precontemplation stage (no plan for screening). Most (93%) agreed that screening was important. In multivariable analyses, compared to those in Action, Precontemplators were less likely to be insured (Odds Ratio [OR]=0.2, 95% CI: 0.03-1.03), to be worried about getting CRC (OR: 0.2, 95% CI: 0.1-0.5), to believe that screening was easy (OR: 0.3, 95% CI: 0.2-0.7), and to report that a physician had recommended screening (OR=0.1, 95% CI: 0.05-0.2). Compared to Contemplators, Precontemplators were more likely to be female (OR: 3.6, 95% CI: 1.2-10.8), and less likely to be worried about getting CRC (OR: 0.3, 95% CI: 0.1-0.8) and to report that a physician had recommended screening (OR=0.2, 95% CI: 0.1-0.5).

Conclusions: Although most respondents agreed that CRC screening was important for them, one-third had no plan for it. Lack of health insurance, lack of physician recommendation, low perceived susceptibility, and perceived testing difficulty were associated with no screening intention. Efforts to increase CRC screening require multi-level interventions targeting patients, providers and access.

Learning Areas:
Assessment of individual and community needs for health education
Communication and informatics
Diversity and culture
Public health or related education
Public health or related research
Social and behavioral sciences

Learning Objectives:
1. Describe stages of colon cancer (CRC) screening adoption among Chinese Americans aged 50-75. 2. Describe factors associated with lack of intention for CRC screening in this population. 3. Recognize multi-level intervention opportunities to promote CRC screening among Chinese Americans.

Keywords: Cancer Screening, Asian Americans

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a clinical psychologist and an Associate Professor at the University of California San Francisco. I have more than 12 years of experience in conducting clinical intervention and outcome research in cancer prevention and tobacco control.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.